Edition:
United States

Bayer AG (BAYZF.PK)

BAYZF.PK on OTC Markets Group

100.00USD
11:00am EST
Change (% chg)

$0.61 (+0.61%)
Prev Close
$99.39
Open
$100.00
Day's High
$100.00
Day's Low
$100.00
Volume
11,445
Avg. Vol
5,818
52-wk High
$128.10
52-wk Low
$91.73

Summary

Name Age Since Current Position

Werner Wenning

70 2012 Chairman of the Supervisory Board

Werner Baumann

53 2016 Chairman of the Management Board, Chief Executive Officer, Member of the Management Board, Chief Strategy and Portfolio Officer

Oliver Zuehlke

47 2015 Vice Chairman of the Supervisory Board

Johannes Dietsch

54 2014 Chief Financial Officer, Member of the Management Board

Liam Condon

48 2016 Member of the Management Board, Head of the Crop Science Division

Hartmut Klusik

59 2016 Member of the Management Board, Director of Human Resources, Technology & Sustainability

Kemal Malik

53 2014 Member of the Management Board, Innovation and the Latin America Region

Erica Mann

57 2016 Member of the Management Board, Head of the Consumer Health Division

Dieter Weinand

56 2016 Member of the Management Board and Head of the Pharmaceuticals Division, North America Region

Paul Achleitner

59 2002 Member of the Supervisory Board

Simone Bagel-Trah

47 2014 Member of the Supervisory Board

Clemens Boersig

67 2007 Member of the Supervisory Board

Thomas Ebeling

57 2012 Member of the Supervisory Board

Thomas Fischer

60 2005 Member of the Supervisory Board

Reiner Hoffmann

60 2006 Member of the Supervisory Board

Yueksel Karaaslan

48 2012 Member of the Supervisory Board

Petra Kronen

51 2000 Member of the Supervisory Board

Frank Loellgen

54 2015 Member of the Supervisory Board

Helmut Panke

69 2007 Member of the Supervisory Board

Sue Rataj

59 2012 Member of the Supervisory Board

Petra Reinbold-Knape

56 2012 Member of the Supervisory Board

Michael Schmidt-Kiessling

56 2012 Member of the Supervisory Board

Klaus Sturany

69 2007 Member of the Supervisory Board

Andre van Broich

45 2012 Member of the Supervisory Board

Heinz Webers

56 2015 Member of the Supervisory Board

Otmar Wiestler

59 2014 Member of the Supervisory Board

Ernst-Ludwig Winnacker

74 1997 Member of the Supervisory Board

Alexander Rosar

Head of Investor Relations

Biographies

Name Description

Werner Wenning

Mr. Werner Wenning is Chairman of the Supervisory Board of Bayer AG as of October 1, 2012. He first joined Bayer on April 1, 1966 as a commercial trainee. After completing his vocational training and a one-year program in finance and accounting, he worked for a year in Corporate Auditing before being sent to Lima, Peru, in 1970 to establish and head up the finance department at the newly founded Bayer Industrial S.A. When he returned to Germany, Wenning spent a further three years in the Corporate Auditing department. In 1978, he went back to Lima as Managing Director and administrative head of the Peruvian company. In 1983, Wenning was appointed head of the staff department of what was then the Health Care Sector in Leverkusen. Three years later he transferred to the Plastics Business Group as head of marketing for thermoplastics. In 1987 he assumed responsibility for this business group’s global marketing operations. Starting on April 1, 1991, he was seconded for a year to the “Treuhandanstalt,” the Berlin-based privatization agency that helped to rebuild the economy in eastern Germany following reunification. In 1992, Wenning was appointed Managing Director of Bayer Hispania Industrial S.A., Barcelona, and Senior Bayer Representative for Spain. In April 1996 he returned to Leverkusen to become head of Corporate Planning and Controlling. Wenning was appointed to the Bayer AG Board of Management as Chief Financial Officer in February 1997 and took over as its Chairman in April 2002. Werner Wenning has been Chairman of the Supervisory Board of E.ON AG, Düsseldorf, since May 2011. He is also a member of the Shareholders' Committee of Henkel AG & Co. KGaA, Düsseldorf. Wenning is a member of the Supervisory Board of Siemens AG, München. Wenning served as Vice President of the German Chemical Industry Association (VCI), Frankfurt, for four years until September 2011 and as VCI President from September 2005 to September 2007. He was also Vice President of the Federation of German Industries (BDI

Werner Baumann

Mr. Werner Baumann is appointed as Chairman of the Management Board, Chief Executive Officer, Member of the Management Board, Chief Strategy and Portfolio Officer at Bayer Aktiengesellschaft effective May 1, 2016. Previously he served as Member of the Management Board, Strategy and Portfolio Management, Europe/Middle East/Africa Region at Bayer AG since January 1, 2016 till April 30, 2016. After studying economics at RWTH Aachen Universitaet and the University of Cologne, he joined Bayer in 1988. His first duties were in the Corporate Finance Department in Leverkusen. In 1991 he transferred to Bayer Hispania Comercial in Barcelona, Spain, to take up a position as controller, becoming assistant to the managing director in 1995. A year later, Baumann moved to Bayer Corporation in Tarrytown, New York, latterly heading up the global Business Planning & Administration organization of the Diagnostics Business Group. In July 2002, Baumann returned to Germany to become a member of the Executive Committee and Head of Central Administration & Organization at Bayer HealthCare. In October 2003 he was appointed a member of the Board of Management of the newly formed subgroup Bayer HealthCare AG, also serving as the company's Labor Director. As a member of the Board of Management and Labor Director of Bayer Schering Pharma AG, Berlin, Germany, from 2006 through September 2009, he actively participated in this company's integration into the subgroup. Prior to October 1, 2014, he served as Bayer AG’s Chief Financial Officer (CFO).

Oliver Zuehlke

Mr. Oliver Zuehlke is Vice Chairman of the Supervisory Board of the company. He joined Bayer AG in Leverkusen, Germany, in 1985 and trained as a chemical production technician. During his training, in 1988, he became a member of the body representing young employees and apprentices. He chaired this body from 1990 to 1994. He was elected a full-time member of the Works Council at the Leverkusen site in 1994 and was Deputy Chairman from 2002 to 2010. Since then, he has also been a member of the Economics Committee of Bayer AG. In 2009, Oliver Zuehlke completed a distance learning course on human resources management. Between 2010 and 2015 Zuehlke was Chairman of the Works Council at the Leverkusen site and also held various functions in the German Mining, Chemical and Power Workers' Union (IG BCE). He was a member of the District Executive, the Regional Executive, the federal industrial group for the chemical industry, and the advisory board. From 2009 to 2015 Zuehlke was Chairman of the Bayer European Forum. In 2014 Zuehlke became a member of the Supervisory Board of Bayer Pharma AG. Since 2015 Zuehlke has been Chairman of the Central Works Council of Bayer AG.

Johannes Dietsch

Mr. Johannes M. Dietsch is Member of the Management Board and Chief Financial Officer at Bayer AG, effective October 1, 2014. After graduating from high school, he joined Bayer as a commercial trainee. On completion of his training in 1984, he held a number of management positions in various departments within the company. He gained several years of overseas experience during two assignments at Bayer Japan, Ltd., latterly as Chief Financial Officer in finance and administration. In 2001 Dietsch was made Head of Corporate Finance in the Finance Division, becoming Head of Finance in the Corporate Center of Bayer AG on July 1, 2002. His area of responsibility included Treasury, Corporate Finance, Financial Controlling, Asset Management Pensions, Mergers & Acquisitions and Taxes. In September 2011, he was appointed as Senior Bayer Representative and CFO for Greater China at Bayer China in Shanghai.

Liam Condon

Mr. Liam Condon is Member of the Management Board, Head of the Crop Science Division of the company. He studied international marketing and languages at Dublin City University and at the Technische Universitaet Berlin. As well as English and German, he also speaks Gaelic, French, Japanese and Mandarin (Chinese). After graduating, Condon joined the former Schering AG and held various sales and marketing positions in the gynecology business in Germany. He then served five years as head of a business unit in Osaka, Japan. On his return to Germany, Condon became Regional Marketing and Medical Director for the Asia-Pacific and Middle East regions at Schering in Berlin. In February 2005, he was appointed Managing Director of Schering in China. Following Bayer’s acquisition of Schering, Condon was named Vice President of Bayer HealthCare China in November 2006. Between 2007 and 2009, he was Managing Director of Bayer HealthCare and General Manager of Bayer Pharma in China. In January 2010, Liam Condon was appointed Managing Director of Bayer HealthCare in Germany and country representative for Bayer Schering Pharma in Germany. In December 2012, he became Chairman of the Board of Management of Bayer CropScience AG. Condon is a member of the Board of Directors of CropLife International, an agricultural industry association.

Hartmut Klusik

Dr. Hartmut Klusik is Member of the Management Board, Director of Human Resources, Technology & Sustainability of the company. He completed his studies in chemistry and gaining his doctorate from the Philipps University in Marburg, Germany, he began his professional career at Bayer’s Wolff Walsrode AG subsidiary in 1984 as a laboratory manager. He then worked as head of operations in various production areas at Wolff Walsrode. In 1990, he transferred to Bayer AG and was appointed head of the company’s crop protection production in Brazil. This was followed by assignments in the United States and Australia. In 1997, Klusik took charge of crop protection active ingredient production in Dormagen and Elberfeld, assuming global responsibility for active ingredient production at Bayer CropScience in Monheim from 2002. In early 2005, he transferred to Bayer HealthCare as head of the Technical Operations Committee. He was appointed to the Bayer HealthCare Executive Committee in July 2005 and was responsible for Product Supply. From November 2005 until his appointment to the Board of Management of Bayer AG, Klusik was a member of the Board of Management of Bayer HealthCare AG and became Labor Director as of October 2009. From March 2011 he was also Labor Director and member of the Board of Management of Bayer Pharma AG.

Kemal Malik

Dr. Kemal Malik is Member of the Management Board, Innovation and the Latin America Region at the company. He studied medicine at Charing Cross and Westminster Medical School (University of London), graduating as a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1987. Malik subsequently spent several years in clinical medicine at the Northwick Park Clinical Research Centre and at Hammersmith Hospital, London. He then held various positions of increasing responsibility in medical affairs and clinical development at Bristol-Myers Squibb in the United Kingdom. Malik joined Bayer in 1995 as Head of Metabolism and Oncology Europe in the then Pharmaceuticals Business Group. He subsequently served as Head of Global Medical Development before being appointed Head of Global Development. Kemal Malik was a member of the Executive Committee of Bayer HealthCare AG from July 1, 2007 until his appointment to the Board of Management of Bayer AG. He was also Head of Global Development and Chief Medical Officer in the Pharmaceuticals Division.

Erica Mann

Ms. Erica Mann is Member of the Management Board, Head of the Consumer Health Division of the company. She holds a degree in Analytical Chemistry and a Marketing Management Diploma from the Institute of Marketing Management in Johannesburg, South Africa. She began her career in 1982 as a medical representative at Eli Lilly & Company in South Africa. This was followed by positions in Marketing at Johnson & Johnson and Lederle Laboratories. In 1992, she became head of the Lederle pharmaceutical business in South Africa before joining Wyeth as Managing Director for South Africa and Sub-Equatorial Africa in 1994. She then held positions of increasing responsibility at the company through 2009. In 2003, she was appointed Managing Director of Wyeth in Australia and New Zealand, where she introduced a range of significant medicines and nutritionals. In April 2009, she became Senior Vice President for the global Nutrition business. Following the acquisition of Wyeth by Pfizer, Mann moved to the United States, where she was President and General Manager of Pfizer’s Nutrition Division and a member of the company’s Senior Management Team. In March 2011, she joined Bayer HealthCare as head of the Consumer Care Division and was appointed to the Bayer HealthCare Executive Committee at the same time. Erica Mann has held executive positions in various industry organizations, including the South African Pharmaceutical Manufacturers’ Association (PMA), Medicines Australia and the International Association of Infant Food Manufacturers. She currently chairs the World Self Medication Industry association, which represents the interests of the global nonprescription (over-the-counter, OTC) medicines industry.

Dieter Weinand

Mr. Dieter Weinand is Member of the Management Board and Head of the Pharmaceuticals Division, North America Region of Bayer Aktiengesellschaft. He earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York. During a career stretching back over 25 years, he has held various responsibilities in commercial, operational and strategic areas of the pharmaceutical industry. These positions included heading business operations in markets in the Asia-Pacific region, Europe, the Middle East, Africa, Latin America and the United States for companies including Pfizer and Bristol-Myers Squibb. He has also been in charge of product marketing in various therapeutic areas, including cardiovascular diseases, oncology, dermatology, immunology, and respiratory and inflammatory diseases. Before moving to Bayer HealthCare, he was President, Global Commercialization & Portfolio Management at Otsuka Pharmaceutical Development & Commercialization Inc. in Princeton, New Jersey, USA. From August 1, 2014, until his appointment to the Board of Management of Bayer AG, Weinand was a member of the Bayer HealthCare Executive Committee and head of the Pharmaceuticals Division.

Paul Achleitner

Dr. Paul Achleitner is an Member of the Supervisory Board at Bayer AG. since April 26, 2002. In addition, he acts as Member of the Company's Presidial and Mediation Committee as well as the Nomination and Human Resources Committees. Until February 7, 2008 Dr. Achleitner was Chairman of the Supervisory Board of Allianz Elementar Lebensversicherungs-AG and Allianz Elementar Versicherungs-AG, and Vice Chairman of the Supervisory Board of Allianz Investment Bank. He was Member of the Supervisory Board of Allianz Lebensversicherungs-AG until May 7, 2008. Until the end of June 2010 he served on the Supervisory Board of Allianz Deutschland AG. In addition, Dr. Achleitner is Member of the Supervisory Board of Allianz Global Investors AG, RWE AG and as of April 2010 also of Daimler AG. Furthermore, he occupies the position of Chairman of the Board of Directors at Allianz Investment Management SE. He holds a degree from Harvard University and earned a Doctorate in Philosophy degree from Universitaet St. Gallen.

Simone Bagel-Trah

Dr. Simone Bagel-Trah is Member of the Supervisory Board at Bayer AG effective April, 2014. Previously she held positions as Chairman of the Supervisory Board of Henkel AG & Co. KGaA and Henkel Management AG and Shareholders Committee of Henkel AG & Co. KGaA. from 1998 to 2000 She is Independent consultant; project management for the Association of Applied Microbiology; coordination of industrial projects for the Pharmaceutical Microbiology department of the University of Bonn. Since 2000 Founding Partner and Director of Antiinfectives Intelligence Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH.

Clemens Boersig

Dr. Clemens A. H. Boersig is Member of the Supervisory Board at Bayer AG since April 2007. Dr. Boersig served as Member of the Supervisory Board of Deutsche Lufthansa AG until April 29, 2008. He occupies the position of Chairman of the Supervisory Board at Deutsche Bank AG. Furthermore, he serves on the Supervisory Board of Daimler AG, Linde AG as well as Emerson Electric Co. In 1973 he obtained a degree in Mathematics as well as Business Administration from Universitaet Mannheim (University of Mannheim). He also earned a Doctorate degree in Economics from Universitaet Mannheim in 1975.

Thomas Ebeling

Mr. Thomas Ebeling is Member of the Supervisory Board of Bayer AG from April 27, 2012. He is Chairman of the Supervisory Board at ProSiebenSat.1 Media AG. since 2009 Chairman of the Executive Board of ProSiebenSat.1 Media AG.

Thomas Fischer

Dr. Thomas Fischer is Member of the Supervisory Board at Bayer AG since October 1, 2005. Additionally, he acts as Member of the Audit Committee of the Company. Dr. Fischer is Member of the Supervisory Board of Bayer MaterialScience AG and Chairman of the Group Managerial Employees’ Committee of Bayer AG.

Reiner Hoffmann

Mr. Reiner Hoffmann is Member of the Supervisory Board at Bayer AG. since October 11, 2006. He is North Rhine District Secretary of the German Mining, Chemical and Energy Industrial Union. Furthermore, Mr. Hoffmann also serves as Member of the Supervisory Board at SASOL Germany GmbH and as of September 2010 also at Evonik Services GmbH. He is Member of the Audit Committee at the Company. since 2014 Chairman of the German Trade Union Confederation

Yueksel Karaaslan

Mr. Yueksel Karaaslan is Member of the Supervisory Board of Bayer AG. since April 27, 2012. He also acts as Chairman of the Works Council of the Berlin site of Bayer, Vice Chairman of the Bayer Central Works Council and Member of the Supervisory Board of Bayer Pharma AG. since 2015 Chairman of the Bayer Group Works Council.

Petra Kronen

Ms. Petra Kronen is Member of the Supervisory Board at Bayer AG since July 2000. Additionally, she acts as Member of the Human Resources Committee of the Company. Ms. Kronen is active as Chairwoman of the Works Council of the Uerdingen site at Bayer AG. Moreover, she also serves as Vice Chairwoman of the Supervisory Board at Bayer MaterialScience AG as of December 7, 2009. since 1999 Chairwoman of the Works Council of the Uerdingen site.

Frank Loellgen

Mr. Frank Loellgen is Member of the Supervisory Board of the company. since November 2015. He served since 2014 North Rhine District Secretary of the German Mining, Chemical and Energy Industrial Union.

Helmut Panke

Dr. Helmut Gunter Wilhelm Panke is Member of the Supervisory Board at Bayer AG since April 27, 2007. He is former Chairman of the Board of Management of BMW AG, Munich. Dr. Panke serves on the Supervisory Board of Microsoft Corporation, Singapore Airlines Limited and UBS AG. He holds a Doctorate in Physics from Ludwig-Maximilians-Universitaet Muenchen. From 2002 – 2006 Served as Chairman of the Board of Management of BMW AG.

Sue Rataj

Ms. Sue H. Rataj is Member of the Supervisory Board at Bayer AG since April 27, 2012. She is Member of the Board of Directors at Cabot Corporation. She is Member of the Board of Directors of Agilent Technologies Inc., Compensation Committee member and member of the Nominating and Corporate Governance Committee.

Petra Reinbold-Knape

Ms. Petra Reinbold-Knape is Member of the Supervisory Board of Bayer AG. since April 27, 2012. She also acts as Northeast District Secretary of the German Mining, Chemical and Energy Industrial Union, and Member of the Supervisory Board at envia Mitteldeutsche Energie AG, Vattenfall Europe Genera tion AG, Vattenfall Europe Business Services GmbH (until May 2012), among others. She is the Member of the Executive Committee of the German Mining, Chemical and Energy Industrial Union, responsible for education/focus groups.

Michael Schmidt-Kiessling

Mr. Michael Schmidt-Kiessling is Member of the Supervisory Board of Bayer AG. since April 27, 2012. He also is Vice Chairman of the Works Council of the Elberfeld site of Bayer and Member of the Supervisory Board at Bayer Pharma AG. Since 1976 Vocational training as a chemical laboratory technician at Bayer AG; initially employed in chemical crop protection research following his vocational training, and then in chemical pharmaceutical research at the Pharmaceutical Research Center in Wuppertal-Aprath.

Klaus Sturany

Dr. Klaus Sturany is Member of the Supervisory Board at Bayer AG. since April 27, 2007. Additionally, Dr. Sturany acts as Chairman of the Company's Audit Committee. He was Member of the Executive Board of RWE AG until April 30, 2007. Dr. Sturany was Member of the Supervisory Board of Commerzbank AG until May 15, 2008. He serves as Vice Chairman of the Supervisory Board of Hannover Rueckversicherung AG and as Member of the Supervisory Board at Heidelberger Druckmaschinen AG, Oesterreichische Industrieholding AG and Sulzer AG. He holds a Doctorate degree in Mathematics from Universitaet Innsbruck, which he gained in 1970, and holds a degree in Economics from Johannes Keppler Universitaet Linz.

Andre van Broich

Mr. Andre van Broich is Member of the Supervisory Board of Bayer AG. since April 27, 2012. He also acts as Chairman of the Works Council of the Dormagen site of Bayer and Member of the Supervisory Board at Bayer CropScience AG. since 2011 Chairman of the Cologne-Bonn District Executive Committee of the German Mining, Chemical and Energy Industrial Union.

Heinz Webers

Mr. Heinz Georg Webers is Member of the Supervisory Board of the company. since July 2015. From 2008 He holds Certification by the German Chamber of Industry and Commerce (IHK) as a change manager.

Otmar Wiestler

Prof. Dr. Otmar D. Wiestler is Member of the Supervisory Board at Bayer AG since October 2014. He is Chairman and Scientific Member of the Management Board of the German Cancer Research Center.

Ernst-Ludwig Winnacker

Prof. Dr. Ernst-Ludwig Winnacker is Member of the Supervisory Board at Bayer AG. since April 1997. He is former President of the German Research Foundation in Bonn. In addition, he is Secretary General of the Human Frontier Science Program as of July 1, 2009. Furthermore, Prof. Dr. Winnacker acts as Member on the Supervisory Board of Wacker Chemie AG and occupies the position of Chairman of the Supervisory Board at Medigene AG. since July 2015 he is Professor-Emeritus for Biochemistry, Ludwig-Maximilians University, Munich.

Alexander Rosar